-
PRIDE Study nutrition
Food frequency questionnaire administered in early pregnancy, assessing multiple macronutrients and micronutrients. -
The EuroTARGET cohort: A European project on TArgeted therapy in renal cell...
EuroTARGET is a European collaborative project designed as an observational study for which patients with mRCC were recruited prospectively in 62 centers. In total, 1,210... -
POM imaging data
Imaging data of the Personalized Parkinson Project, including structural and functional MRI. -
PRIDE Study obstetric records
Selected clinical data from obstetric records covering the pregnancy period and puerperium. Necessitates additional consent, provided by ~70% of participants -
PRIDE Study blood samples
First trimester blood samples (plasma, serum, whole blood) of ~1000 PRIDE Study participants, available for genetic and biochemical analyses. Stored at -80°C. -
PRIDE Study medication diaries
6-week medication diaries covering prescription and over-the counter use, administered in the second trimester of pregnancy. Available for 1516 PRIDE Study participants... -
ReLife study food frequency questionnaire
A 163-item Food Frequency questionnaire was completed at 3 (n=352), 12 (n=330) and 24 months (n=275) after surgery. -
ReLife study blood samples
Serum and EDTA plasma samples were collected at 3 (n=335), 12 (n=266) and 24 months (n=237) after surgery. EDTA plasma samples have been analysed for CRP, IL-6, adiponectin, and... -
UroLife study molecular subtypes
Molecular subtype based on immunohistrochemistry performed on tissue microarrays is available for 389 T1 NMIBC tumours. -
UroLife study fluid intake and micturition diary
A 4-day fluid and micturition diary was completed at 3 (n=1146) and 15 months (n=1000) after diagnosis. -
PRIDE-BIOME project
Subproject among 116 PRIDE Study participants. Gut microbiome data for maternal samples collected at gestational weeks 20 and 34, and 2 months after the estimated date of... -
PRIDE Study paternal questionnaire data
Questionnaire data focusing on paternal exposures the 3 months before conception. Completed by the biological father, <50% participation rate. -
UroLife study general questionnaire
Patients with non-muscle invasive bladder cancer (n=1512) completed paper-and-pencil or web-based questionnaires at 6 weeks (referring to pre-diagnosis lifestyle; n=1486) and 3... -
ReLife study general questionnaire
Patients with localized stage I-III renal cell cancer (n=365) completed paper-and-pencil or web-based questionnaires at 3 months (n=368), 12 months (n=317), and 24 months... -
ReLife study quality of life questionnaire
The EORTC QLQ-C30 was completed at 3 (n=365), 12 (n=317) and 24 months (n=279) after surgery. -
COVID-19 dataset of aggregated data.
This dataset contains aggregated data from 42193 individuals from COVID Population 12 Italy, Subgroup 2. -
COVID-19 dataset with individual level data
This dataset contains individual level data from 42193 individuals from COVID Population 12 Italy, Subgroup 2. -
COVID-19 GWAS and Allele Frequency Lookup Dataset with Population 12...
This dataset is being used as part of the GDI Milestone 8, containing VCFs and phenotypic data in CSV format about 41514 samples. The dataset consists only of synthetic data. -
COVID-19 GWAS and Allele Frequency Lookup Dataset for GDI MS 8
This is the first part of the split 11 of the synthetic data dedicated for the GDI MS8 -
GDI COVID 19 synthetic dataset (Population 11 Finland, Subgroup 2)
This dataset contains the pheno-clinical and genomic information of 42046 individuals from COVID Population 11 Finland, Subgroup 2. 2010 are affected by Phenotype 1, 2010 are...
U kunt ook het register raadplegen met behulp van de API (see API documentatie).